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OBJECTIVE— The role of intrauterine hyperglycemia and future risk of type 2 diabetes in
human offspring is debated. We studied glucose tolerance in adult offspring of women with
either gestational diabetes mellitus (GDM) or type 1 diabetes, taking the impact of both intra-
uterine hyperglycemia and genetic predisposition to type 2 diabetes into account.
RESEARCHDESIGNANDMETHODS— The glucose tolerance status following a 2-h
75-g oral glucose tolerance test (OGTT) was evaluated in 597 subjects, primarily Caucasians,
aged 18–27 years. They were subdivided into four groups according to maternal glucose me-
tabolism during pregnancy and genetic predisposition to type 2 diabetes: 1) offspring of women
with diet-treated GDM (O-GDM), 2) offspring of genetically predisposed women with a normal
OGTT (O-NoGDM), 3) offspring of women with type 1 diabetes (O-type 1), and 4) offspring of
women from the background population (O-BP).
RESULTS— The prevalence of type 2 diabetes and pre-diabetes (impaired glucose tolerance
or impaired fasting glucose) in the four groups was 21, 12, 11, and 4%, respectively. In multiple
logistic regression analysis, the adjusted odds ratios (ORs) for type 2 diabetes/pre-diabetes were
7.76 (95% CI 2.58–23.39) in O-GDM and 4.02 (1.31–12.33) in O-type 1 compared with O-BP.
In O-type 1, the risk of type 2 diabetes/pre-diabetes was significantly associated with elevated
maternal blood glucose in late pregnancy: OR 1.41 (1.04–1.91) per mmol/l.
CONCLUSIONS— A hyperglycemic intrauterine environment appears to be involved in the
pathogenesis of type 2 diabetes/pre-diabetes in adult offspring of primarily Caucasian women
with either diet-treated GDM or type 1 diabetes during pregnancy.
Diabetes Care 31:340–346, 2008
The rapid global rise in the prevalenceof type 2 diabetes constitutes ahealth threat to the individual and is
a major burden for health economy.
Therefore, it is crucial to identify specific
risk groups, targeting preventive strate-
gies. Studies of developmental origins of
health and disease have focused on the
possible role of intrauterine hyperglyce-
mia in the pathogenesis of type 2 diabetes
(1). Maternal glucose crosses placenta
easily, and maternal hyperglycemia leads
to intrauterine hyperglycemia, fetal hy-
perinsulinemia, and possible modifica-
tion of growth and development of the
fetus (2).
Pronounced hyperglycemia in rela-
tion to pregnancies of women with type 1
diabetes as well as mild hyperglycemia, as
seen among women with gestational dia-
betes mellitus (GDM), are both associated
with increased fetal growth and perinatal
morbidity (3,4). Also, less severe forms of
glucose intolerance are associated with in-
creased feto-maternal morbidity (5).
In animal studies, intrauterine hyper-
glycemia increases the risk of abnormal
glucose tolerance, diabetes, overweight,
and insulin resistance in offspring (6–
10). Despite very convincing animal stud-
ies, questions still exist concerning the
long-term impact of intrauterine hyper-
glycemia in humans, especially regarding
the impact in adult Caucasians. Observa-
tional and prospective studies among the
Pima Indians and from the Chicago group
support the findings of animal studies
(11–18). The studies of the Pima Indians
examine children and adult offspring in
contrast to the majority of the other stud-
ies, in which offspring before the end of
puberty are investigated (14–16,18). Be-
cause of the very specific genetics of the
Pima Indians, the results are not directly
applicable to other populations (11–
13,19). Furthermore, some of the other
studies have limitations: small number of
participants (17), high number of drop-
outs during follow-up (14,15), and anal-
yses including maternal type 1 and type 2
diabetes together (16). Only one fol-
low-up study of children from a small
randomized trial in women with GDM
has been performed—without definitive
conclusions (20).
Thus, in the present paper we aimed
to evaluate the prevalence of type 2 dia-
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betes and pre-diabetes in young adult off-
spring of women with either diet-treated
GDM or type 1 diabetes in a mainly Nor-
dic Caucasian population, taking the im-
pact of both intrauterine hyperglycemia
and genetic predisposition to type 2 dia-
betes into account.
RESEARCH DESIGN AND
METHODS— Through 2002–2005,
we conducted a follow-up study of 597
adult offspring born to women with GDM
or type 1 diabetes and from two control
groups. All subjects were born at the De-
partment of Obstetrics, Rigshospitalet,
Denmark, from 1978 to 1985, and cou-
pling between mother and child was pos-
sible through the Danish Civil Registrar
System. We included singletons only, and
if more than one sibling from the study
period met criteria for inclusion, only the
oldest was invited.
Protocol was in accordance with the
Declaration of Helsinki and approved by
the local ethical committee. All partici-
pants gave a written consent before taking
part in the survey.
We sought a model to evaluate the
possible impact of exposure to intrauter-
ine hyperglycemia both in subjects with a
relatively high genetic predisposition to
type 2 diabetes and in subjects with a rel-
atively low genetic predisposition. Be-
cause there was no universal screening for
GDM during 1978 –1985 and because
there currently are no available tools for
adequate genetic testing for type 2 diabe-
tes, our model is based on certain as-
sumptions concerning phenotypic traits
and genetic predisposition to type 2
diabetes.
From 1978 to 1985, Danish routine
screening of pregnant women for GDM
was based on risk indicators (family his-
tory of diabetes [unspecified], 20%
overweight prepregnancy, previous
GDM, previous delivery of a macrosomic
baby [4.500 g], and glucosuria) and
fasting blood glucose (21). Women with
risk indicators and two consecutive fast-
ing capillary blood glucose measurements
4.1 mmol were offered a 3-h 50-g oral
glucose tolerance test (OGTT). Until Sep-
tember 1982, glucose during OGTT was
measured in venous plasma, while capil-
lary whole blood was used thereafter as
previously published (22). The OGTT
was defined as abnormal if more than two
of seven values during the test exceeded
the mean 3 SDs for a reference group of
normal-weight nonpregnant women
without a family history of diabetes (23).
We assumed all women, examined by an
OGTT on this background, to have a rel-
atively high genetic predisposition to type
2 diabetes independently of the result of
the OGTT. The prevalence of GDM was
2% (21), meaning that 98% did not have
GDM. Accordingly, the background pop-
ulation was regarded as having a relatively
low genetic risk of developing type 2 dia-
betes. Women with type 1 diabetes were
regarded as having comparably low ge-
netic risk of developing type 2 diabetes.
Based on these assumptions, our
model consists of four groups enriched
with different combinations of intrauter-
ine hyperglycemia and genetic predispo-
sition to type 2 diabetes (Fig. 1): 1)
offspring of women with GDM (O-GDM)
(intrauterine hyperglycemia and a rela-
tively high genetic predisposition to type
2 diabetes), 2) offspring of women who
were screened for GDM because of risk
indicators and elevated fasting blood glu-
cose but had a normal OGTT (O-
NoGDM) (no intrauterine hyperglycemia
and a relatively high genetic predisposi-
tion to type 2 diabetes), 3) offspring of
women with type 1 diabetes (O-type 1)
(intrauterine hyperglycemia and a rela-
tively low genetic predisposition to type 2
diabetes), and 4) offspring of women from
the background population (O-BP) (no
intrauterine hyperglycemia and a rela-
tively low genetic predisposition to type 2
diabetes).
All mothers of O-GDM were diet-
treated only. Mothers of O-NoGDM had
all glucose values during the OGTT below
the mean 2 SDs of the reference group
(23). Mothers of O-type 1 fulfilled three
criteria: onset of diabetes at age 40
years, a classical history, and insulin treat-
ment started 6 months after diagnosis.
The background population was defined
as women from the local community re-
ferred for antenatal care and delivery.
Examination at follow-up
After an overnight fast, participants
without known diabetes had a 2-h 75-g
OGTT with venous sampling at 0 and 120
min. Participants with known diabetes
only had fasting venous samples. Weight
and height were measured in light cloth-
ing and without shoes, and a questionnaire
regarding information on occupation,
health, medication, smoking, physical ac-
tivity (24), and paternal diabetes status was
filled in.
Biochemical methods
Blood samples for glucose measure-
ments were drawn in heparin–sodium
fluoride vials, kept on ice, centrifuged,
plasma separated within 30 min, and
analyzed on a Cobas Mira analyzer by
Figure 1—Subjects in the study stratified according to relative genetic predisposition to type 2
diabetes and exposure to intrauterine hyperglycemia.
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either the enzymatic ultraviolet test,
HK/G-6PHD method (ABX Diagnostics
Glucose HK 125; Horiba-ABX, Mont-
pellier, France), or the glucose dehy-
drogenase catalyzed oxidation method
(Gluc-DH Method; Merck, Darmstadt,
Germany). Serum C-peptide was mea-
sured automatically by a fluoroimmu-
noassay using monoclonal antibodies
(AutoDELFIA C-peptide kit; Perkin-
Elmer Life and Analytical Sciences,
Wallac Oy, Turku, Finland). GAD65
autoantibodies (GAD65abs) were de-
tected by ELISA (GAD65 Autoantibody
ELISA kit; RSR, Cardiff, U.K.) and de-
fined as positive when 5 units/ml.
Covariates
Outcome. The prevalence of either type
2 diabetes or pre-diabetes in the offspring
at follow-up was our primary outcome.
The OGTTs were evaluated according to
World Health Organization criteria of
1999 (25). Classification of diabetes type
was based on history, medical records,
and levels of fasting C-peptide and
GAD65ab. Pre-diabetes was defined as ei-
ther impaired glucose tolerance or
impaired fasting glucose.
Exposure. We used group (O-GDM, O-
NoGDM, O-type 1, and O-BP) as an esti-
mate of different levels of intrauterine
hyperglycemia in analyses including all
offspring. In a subanalysis of offspring
born to women having an OGTT during
pregnancy, we included either fasting or
2-h blood glucose from this OGTT in the
analyses. In women with type 1 diabetes,
estimates of mean blood glucose in the
first trimester and in late pregnancy were
available, and the predictive value of these
variables were tested for O-type 1.
Potential confounding covariates. So-
cioeconomic position was based on the
highest occupational status of the parents
at present and coded into family social
class I–V in accordance with the stan-
dards of the Danish National Institute of
Social Research, similar to the British Reg-
istrar General’s Classification I–V. We
added a social class VI representing peo-
ple on transfer income, including sickness
benefits and disability pension (26), and
dichotomized the variable into family so-
cial class (V–VI vs. I–IV). Ethnic origin
was defined as Nordic Caucasian if the
mother originated from Denmark, Nor-
way, Sweden, or Iceland (yes vs. no). Pa-
ternal diabetes was defined as unspecified
diabetes at follow-up (yes vs. no). Mater-
nal family history of diabetes was defined
as unspecified diabetes in a first-degree
relative on the maternal side (yes vs. no).
Maternal smoking during pregnancy
was entered (1 cigarette/day, yes vs.
no), as were age at delivery (25 vs.25
years), parity (1 partus versus nullipar-
ity), and pregestational BMI (25 vs.
25 kg/m2) of mothers. Offspring sex
was entered (male vs. female), as were
physical activity (30 vs.30 min/day),
current smoking (1 cigarette/day, yes
vs. no), and age (years) of offspring. We
considered offspring BMI (25 vs. 25
kg/m2), to be a possible mediating covari-
ate in the casual pathway from exposure
to intrauterine hyperglycemia to glucose
metabolism in offspring.
Offspring were defined as small or
large for gestational age (SGA and LGA,
respectively) according to a Danish stan-
dard population (27). In O-GDM and es-
pecially in O-type 1 birth weight,
gestational age and offspring risk of be-
coming LGA were extensively influenced
by factors attributed to the disease as well
as to interventions related to treatment.
Therefore, we considered the following
covariates as both potential mediators and
proxy variables for the two treated groups
(O-GDM and O-type 1): preterm delivery
(37 weeks’ gestation; yes vs. no), birth
weight (grams), gestational age (days),
SGA (yes vs. no) and LGA (yes vs. no). For
this, we studied the possible effect of
these variables on offspring risk of type 2
diabetes/pre-diabetes without the
“group” covariate in the model. We per-
formed analyses including offspring from
all four groups together but also analyses
separately for offspring in the two treated
groups (O-GDM and O-type 1) and off-
spring in the two untreated groups (O-
NoGDM and O-BP).
Statistical analyses
Continuous variables are given as
mean  SDs or median (2.5th–97.5th
percentiles). Differences between groups
were analyzed with the 2 test, ANOVA,
Student’s t test, Kruskal-Wallis test, or the
Mann-Whitney test when appropriate.
Post hoc tests were corrected for multiple
comparisons using the Bonferroni
method. P values were multiplied by four
as we compared O-BP with the other three
groups, as well as O-GDM with O-
NoGDM. First we did simple logistic re-
gression analyses, giving the unadjusted
odds ratio (OR) of having type 2 diabetes/
pre-diabetes for each of the covariates.
Secondly, we used a “change-in-estimate
method” (28) to assess confounding. Co-
variates that altered the unadjusted ORs
of type 2 diabetes/pre-diabetes by more
than 10% were considered confounders.
Multiple logistic regression models in-
cluded only confounders, and they were
not reduced. The results of the logistic
regression analyses are expressed as ORs
(95% CI). All tests were two tailed, and a
significance level of 0.05 was chosen.
Data were processed using SPSS (version
13.0; SPSS, Chicago, IL).
RESULTS
Characteristics of the study
population
The overall participation rate in the
study was 56% (597 of 1,066) (Fig. 1).
Among the subjects lost to follow-up,
40% did not respond, 34% refused to par-
ticipate, 10% had emigrated, 6% did not
show up, 5% had died, and 5% had other
reasons not to participate. The participa-
tion rate was comparable in the four
groups.
Table 1 gives baseline data from the
original medical records on the pregnant
women in the four groups. There was no
difference between participants and sub-
jects lost to follow-up except for a slightly
lower pregestational maternal BMI (21.7
vs. 21.9 kg/m2, P  0.04) and a higher
rate of Nordic Caucasian mothers among
participants (94 vs. 86%, P  0.001).
OGTTs were performed at 33 weeks’
gestation (17–39 weeks). The prevalence
of risk indicators in mothers of O-GDM
and O-NoGDM was comparable accord-
ing to family history of diabetes (30 vs.
35%, P  0.4), 20% overweight
prepregnancy (30 vs. 24%, P 0.3), pre-
vious delivery of a macrosomic baby (5 vs.
11%, P  0.08), and glucosuria (41 vs.
42%, P  0.8). Also, the prevalence of
more than one risk indicator was compa-
rable (21 vs. 15%, P  0.2), but slightly
more mothers of O-GDM had GDM pre-
viously (9 vs. 2%, P 0.02). As expected,
women with GDM had a higher fasting
(5.2 vs. 4.7 mmol/l) and 2-h (7.8 vs. 5.2
mmol/l) glucose (P  0.001).
Women with type 1 diabetes had 12
years (1–26 years) duration of diabetes,
and 52% had late diabetic complications
(retinopathy or nephropathy). The ma-
jority was on two or four intakes of insulin
per day, with insulin dosage increasing
from 43 IU (13 IU) to 74 IU (20 IU) daily
during pregnancy. Twice during preg-
nancy, women with type 1 diabetes were
hospitalized for 3 days and blood glucose
measured seven times per day in capillary
Role of hyperglycemia in offspring risk of diabetes
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whole blood. In the first trimester, mean
blood glucose was 8.9 2.8 mmol/l, and
in late pregnancy, within the last 4 weeks
before the estimated date of delivery, it
was 6.8  1.8 mmol/l.
Data at follow-up. Table 1 and online
appendix 1 (available at http://dx.doi.org/
10.2337/dc07-1596) give data on off-
spring at follow-up. The prevalence of
type 2 diabetes/pre-diabetes was 21% in
O-GDM, 12% in O-NoGDM, and 11% in
O-type 1 compared with 4% in O-BP.
Only one of the 11 cases of type 2 diabetes
was known before the study, the remain-
ing diagnosed during the study. Two of
the nine cases of type 1 diabetes were di-
agnosed during the study. Both were O-
type 1, presenting with classical
hyperglycemic symptoms, 2-h plasma
glucose 30 mmol/l, and ketonuria.
O-GDM had significantly higher fast-
ing and 2-h plasma glucose than O-BP.
Also, O-NoGDM had significantly higher
fasting plasma glucose than O-BP. Fi-
nally, O-type 1 had significantly higher
2-h plasma glucose than O-BP. BMI was
significantly higher in O-GDM, O-
NoGDM, and O-type 1 than in O-BP.
Online appendix 2 shows risk of type
2 diabetes/pre-diabetes in the four off-
spring groups and effects of the potential
confounding covariates. The unadjusted
OR for type 2 diabetes/pre-diabetes was
markedly increased in O-GDM, O-
NoGDM, and O-type 1 compared with
that in O-BP. Adjustment for maternal
family history of diabetes, maternal over-
weight, and offspring age (Model 1)
slightly reduced this association; ORs
were as follows: 7.76 (95% CI 2.58 –
23.39) in O-GDM, 4.46 (1.38–14.46) in
O-NoGDM, and 4.02 (1.31–12.33) in O-
type 1 compared with O-BP. When O-
GDM was compared with O-NoGDM, the
OR was 1.74 (0.89–3.40). Additional ad-
justment for offspring overweight (Model
2) further decreased the association but
did not change the pattern.
In O-type 1, risk of type 2 diabetes/
pre-diabetes was significantly associated
with elevated maternal glucose in late
pregnancy (OR 1.41 [95% CI 1.04 –
1.91]) per millimole when adjusted for
covariates included in Model 1. Further
adjustment for offspring overweight did
not change this.
Maternal age at delivery, ethnicity,
smoking during pregnancy, parity, pater-
nal diabetes status at follow-up, family so-
cial class, sex, offspring physical activity,
and offspring smoking habits were not
found to be confounders and had no ef-
fect on offspring risk of type 2 diabetes/
pre-diabetes when entered in multiple
logistic regression models. We found no
interaction between groups and covari-
ates in the two models.
No associations between birth
weight, gestational age, preterm delivery,
LGA, or SGA and offspring risk of type 2
diabetes/pre-diabetes were found, neither
when all offspring were studied together
nor when offspring were studied in sub-
groups. Furthermore, ORs for type 2 dia-
betes/pre-diabetes did not change
significantly when these variables were
forced into the logistic regression models.
CONCLUSIONS— We found a high
prevalence of type 2 diabetes/pre-diabetes
among adults exposed to a hyperglycemic
intrauterine environment. More than
20% of offspring born to mothers with
diet-treated GDM and more than 10% of
offspring born to mothers with type 1 di-
abetes had type 2 diabetes/pre-diabetes at
the age of 22 years. Compared with off-
spring from the background population,
the adjusted risks of type 2 diabetes/pre-
diabetes were eight- and fourfold in-
creased, respectively, and this was not
explained by differences in offspring
overweight, birth weight, or gestational
age. Furthermore, we found an associa-
tion between elevated maternal blood
glucose in late pregnancy and type 2 dia-
betes/pre-diabetes in offspring of women
with type 1 diabetes.
Strengths and limitations of this
study
We had a high number of subjects
with long-term follow-up, a high partici-
pation rate, an internal control group, and
data on many potential confounding co-
variates, including paternal diabetes sta-
tus, social class, physical activity, and
levels of C-peptide and GAD65abs in off-
spring. A low prevalence of GDM in our
background population has previously
been documented in O-BP (21), suggest-
ing that the majority of mothers had a
normoglycemic intrauterine milieu. Un-
diagnosed cases of GDM among mothers
of O-BP would only push our results to-
ward the null hypothesis and thus under-
rate the difference between the O-BP and
the three other groups. Pregnant women
with type 1 diabetes had documented
high glucose values during pregnancy,
and although we did not document high
glucose levels continuously during preg-
nancy in the diet-treated GDM mothers,
we have previously demonstrated an im-
pact of a hyperglycemic milieu on the fe-
tus in a similar group of diet-treated
women with GDM (29), suggesting a hy-
perglycemic environment also in O-
GDM. However, we are aware that diet
treatment after diagnosis of GDM may re-
duce the predictive value of glycemia dur-
ing OGTT, leading to an underestimation
of the difference between O-GDM and O-
NoGDM. Nevertheless group and fasting
or 2-h glucose values are crude estimates
of maternal glucose metabolism during
pregnancy. In the two groups with a rel-
atively high genetic predisposition in our
model, we have documented a higher
prevalence of maternal family history of
diabetes (30 and 35%) compared with the
two groups with a low genetic predispo-
sition (16 and 20%). According to our
model, the observed differences in the
prevalence of type 2 diabetes/pre-diabetes
between O-GDM and O-NoGDM (21 vs.
12%) and between O-type 1 and O-BP
(11 vs. 4%) may be interpreted as an effect
of maternal hyperglycemia, whereas the
differences between O-GDM and O-type
1 (21 vs. 11%) and between O-NoGDM
and O-BP (12 vs. 4%) may be interpreted
as an effect of genetics (online appendix
1). These indications of an effect of ma-
ternal hyperglycemia are supported by
multiple logistic regression analysis, as
ORs for type 2 diabetes/pre-diabetes were
higher in O-type 1 compared with O-BP
(4.02 [95% CI 1.31–12.33]) and in O-
GDM compared with O-NoGDM (1.74
[0.89 –3.40]), even though the latter
didn’t reach the level of significance. Fi-
nally, the significant association between
higher glucose levels in late pregnancy
and type 2 diabetes/pre-diabetes in O-
type 1 supports the hypothesis that intra-
uterine hyperglycemia plays a role in the
pathogenesis of type 2 diabetes in off-
spring. We find that bias from losses to
follow-up is unlikely. Long-term studies
of the risk of type 2 diabetes in normogly-
cemic women with risk indicators for
GDM (the O-NoGDM group) are lacking,
and whether the observed difference in
the prevalence of type 2 diabetes/pre-
diabetes between O-GDM and O-
NoGDM is due to a more pronounced
intrauterine hyperglycemia in O-GDM,
stronger genetic predisposition, postnatal
environmental factors, or a combination
cannot be further elucidated from our
data. A more ideal control group of O-
GDM might have been discordant sib-
lings, but that model wasn’t feasible in our
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population, with its low GDM rate and
the screening program used.
The high prevalence of type 2 diabe-
tes/pre-diabetes in adult offspring of
women with type 1 diabetes has not pre-
viously been documented but is in accor-
dance with studies of children born to
women with type 1 diabetes (14,16). Fur-
thermore, a small study found a higher
prevalence of impaired glucose tolerance
and decreased insulin secretion among
adult offspring of mothers compared with
offspring of fathers with type 1 diabetes
(17).
The significant association between
higher glucose levels in late pregnancy in
mothers with type 1 diabetes and the in-
cidence of type 2 diabetes/pre-diabetes in
offspring has not been reported previ-
ously but is supported by the finding of an
association between maternal 2-h glucose
during OGTT and offspring glucose me-
tabolism in glucose-tolerant Pima Indians
(30).
This study is the first to show a high
prevalence of type 2 diabetes/pre-diabetes
in adult offspring of mothers with GDM in
a primarily Caucasian population. This
finding is in accordance with results from
high-risk populations (11) and studies of
children from Caucasian populations
(14,16).
Abnormal glucose tolerance is associ-
ated with either decreased insulin secre-
tion, decreased insulin sensitivity, or a
combination of both. The few human
studies looking into this in offspring of
diabetic women give various results with
decreased insulin sensitivity reported by
some authors (14,31–33) and decreased
insulin secretion by others (14,17,34).
In conclusion, the prevalence of
type 2 diabetes/pre-diabetes is mark-
edly increased among adult, primarily
Nordic Caucasian, offspring born to
women with hyperglycemia during
pregnancy, as seen in diet-treated GDM
and type 1 diabetes. Our findings sup-
port the hypothesis that a hyperglyce-
mic intrauterine environment plays a
role in the pathogenesis of type 2 diabe-
tes. Identification of risk groups gives
unique opportunities for lifestyle inter-
ventions; furthermore, aiming at a nor-
moglycemic intrauterine environment
in pregnant women may reduce the risk
of type 2 diabetes in future generations.
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